By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swift Biosciences announced on Wednesday the recent completion of a $3 million Series A financing round led by venture firm DFJ Mercury.

Also participating in the round were several unnamed Michigan-based individual investors who provided seed funding to Swift when it launched in January. The company also said that Daniel Watkins, a managing director at DFJ Mercury, is joining Swift's board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.